{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:16:15Z","timestamp":1790306175373,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03798-0","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:01:32Z","timestamp":1712116892000},"page":"906-915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests"],"prefix":"10.1007","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-9354","authenticated-orcid":false,"given":"Jorge Gabriel","family":"Ruiz-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Fern\u00e1ndez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"3798_CR1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"P. Mulatero, S. Monticone, J. Deinum, L. Amar, A. Prejbisz, M.-C. Zennaro, F. Beuschlein, G.P. Rossi, T. Nishikawa, A. Morganti, T.M. Seccia, Y.-H. Lin, F. Fallo, J. Widimsky, Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J. Hypertens. 38, 1919\u201328 (2020)","journal-title":"J. Hypertens."},{"key":"3798_CR2","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC K\u00e4yser","year":"2016","unstructured":"S.C. K\u00e4yser, T. Dekkers, H.J. Groenewoud, G.J. van der Wilt, J. Carel Bakx, M.C. van der Wel, A.R. Hermus, J.W. Lenders, J. Deinum, Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis. J. Clin. Endocrinol. Metab. 101, 2826\u201335 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"J.M. Brown, M. Siddiqui, D.A. Calhoun, R.M. Carey, P.N. Hopkins, G.H. Williams, A. Vaidya, The unrecognized prevalence of primary aldosteronism: A cross-sectional study. Ann. Intern. Med. 173, 10\u201320 (2020)","journal-title":"Ann. Intern. Med."},{"key":"3798_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajh\/hpw003","volume":"29","author":"W Kawarazaki","year":"2016","unstructured":"W. Kawarazaki, T. Fujita, The role of aldosterone in obesity-related hypertension. Am. J. Hypertens. 29, 415\u201323 (2016)","journal-title":"Am. J. Hypertens."},{"key":"3798_CR5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.surg.2019.03.036","volume":"167","author":"VM Gershuni","year":"2020","unstructured":"V.M. Gershuni, D.S. Herman, R.R. Kelz, R.E. Roses, D.L. Cohen, S.O. Trerotola, D.L. Fraker, H. Wachtel, Challenges in obesity and primary aldosteronism: Diagnosis and treatment. Surgery 167, 204\u201310 (2020)","journal-title":"Surgery"},{"key":"3798_CR6","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1210\/jc.2018-00866","volume":"103","author":"Y Ohno","year":"2018","unstructured":"Y. Ohno, M. Sone, N. Inagaki, T. Yamasaki, O. Ogawa, Y. Takeda, I. Kurihara, H. Umakoshi, T. Ichijo, T. Katabami, N. Wada, Y. Ogawa, T. Yoshimoto, J. Kawashima, M. Watanabe, Y. Matsuda, H. Kobayashi, H. Shibata, S. Miyauchi, K. Kamemura, T. Fukuoka, K. Yamamoto, M. Otsuki, T. Suzuki, M. Naruse, Obesity as a key factor underlying idiopathic hyperaldosteronism. J. Clin. Endocrinol. Metab. 103, 4456\u201364 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR7","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1210\/clinem\/dgad400","volume":"109","author":"JG Ruiz-S\u00e1nchez","year":"2023","unstructured":"J.G. Ruiz-S\u00e1nchez, M. Paja-Fano, M. Gonz\u00e1lez Boillos, B. Pla Peris, E. Pascual-Corrales, A.M. Garc\u00eda Cano, P. Parra Ram\u00edrez, P. Mart\u00edn Rojas-Marcos, A. Vicente Delgado, E. G\u00f3mez Hoyos, R. Ferreira, I. Garc\u00eda Sanz, M. Recasens Sala, R. Barahona San Millan, M.J. Pic\u00f3n C\u00e9sar, P. D\u00edaz Guardiola, J.J. Garc\u00eda Gonz\u00e1lez, C.M. Perdomo, L. Manj\u00f3n Migu\u00e9lez, R. Garc\u00eda Centeno, J.C. Percovich, \u00c1. Rebollo Rom\u00e1n, P. Gracia Gimeno, C. Robles L\u00e1zaro, M. Morales-Ruiz, F.A. Hanzu, M. Araujo-Castro, Effect of obesity on clinical characteristics of primary aldosteronism patients at diagnosis and postsurgical response. J. Clin. Endocrinol. Metab. 109, e379\u2013e388 (2023)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","volume":"131","author":"MN Pratt-Ubunama","year":"2007","unstructured":"M.N. Pratt-Ubunama, M.K. Nishizaka, R.L. Boedefeld, S.S. Cofield, S.M. Harding, D.A. Calhoun, Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 131, 453\u20139 (2007)","journal-title":"Chest"},{"key":"3798_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","volume":"11","author":"A Di Murro","year":"2010","unstructured":"A. Di Murro, L. Petramala, D. Cotesta, L. Zinnamosca, E. Crescenzi, C. Marinelli, M. Saponara, C. Letizia, Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism. J. Renin-Angiotensin-Aldosterone Syst. 11, 165\u201372 (2010)","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"3798_CR10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/a-1133-7255","volume":"52","author":"A Pecori","year":"2020","unstructured":"A. Pecori, F. Buffolo, J. Pieroni, V. Forestiero, E. Sconfienza, F. Veglio, P. Mulatero, S. Monticone, Primary aldosteronism and obstructive sleep apnea: Casual associationor pathophysiological link. Horm. Metab. Res. 52, 366\u201372 (2020)","journal-title":"Horm. Metab. Res."},{"key":"3798_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","volume":"38","author":"S Monticone","year":"2020","unstructured":"S. Monticone, E. Sconfienza, F. D\u2019Ascenzo, F. Buffolo, F. Satoh, L.A. Sechi, F. Veglio, P. Mulatero, Renal damage in primary aldosteronism: a systematic review and meta-analysis. J. Hypertens. 38, 3\u201312 (2020)","journal-title":"J. Hypertens."},{"key":"3798_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12020-021-02704-2","volume":"73","author":"M Fern\u00e1ndez-Arg\u00fceso","year":"2021","unstructured":"M. Fern\u00e1ndez-Arg\u00fceso, E. Pascual-Corrales, N. Bengoa Rojano, A. Garc\u00eda Cano, L. Jim\u00e9nez Mendiguch\u00eda, M. Araujo-Castro, Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study. Endocrine 73, 439\u201346 (2021)","journal-title":"Endocrine"},{"key":"3798_CR13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","volume":"42","author":"Y Akehi","year":"2019","unstructured":"Y. Akehi, T. Yanase, R. Motonaga, H. Umakoshi, M. Tsuiki, Y. Takeda, T. Yoneda, I. Kurihara, H. Itoh, T. Katabami, T. Ichijo, N. Wada, Y. Shibayama, T. Yoshimoto, K. Ashida, Y. Ogawa, J. Kawashima, M. Sone, N. Inagaki, K. Takahashi, M. Fujita, M. Watanabe, Y. Matsuda, H. Kobayashi, H. Shibata, K. Kamemura, M. Otsuki, Y. Fujii, K. Yamamoto, A. Ogo, S. Okamura, S. Miyauchi, T. Fukuoka, S. Izawa, S. Hashimoto, M. Yamada, Y. Yoshikawa, T. Kai, T. Suzuki, T. Kawamura, M. Naruse, High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: A large, multicenter cohort study in Japan. Diabetes Care 42, 938\u201345 (2019)","journal-title":"Diabetes Care"},{"key":"3798_CR14","doi-asserted-by":"crossref","unstructured":"G. Hanslik, H. Wallaschofski, A. Dietz, A. Riester, M. Reincke, B. Allolio, K. Lang, I. Quack, L.C. Rump, H.S. Willenberg, F. Beuschlein, M. Quinkler, A. Hannemann, participants of the German Conn\u2019s Registry. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry. Eur. J. Endocrinol. 173, 665\u201375 (2015)","DOI":"10.1530\/EJE-15-0450"},{"key":"3798_CR15","first-page":"dgz293","volume":"105","author":"Y Hu","year":"2020","unstructured":"Y. Hu, J. Zhang, W. Liu, X. Su, Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension. J. Clin. Endocrinol. Metab. 105, dgz293 (2020)","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"3798_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti, T.A. Williams, F. Veglio, F. Gaita, P. Mulatero, Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6, 41\u201350 (2018)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3798_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/a-1141-5989","volume":"52","author":"C-T Pan","year":"2020","unstructured":"C.-T. Pan, C.-H. Tsai, Z.-W. Chen, Y.-Y. Chang, V.-C. Wu, C.-S. Hung, Y.-H. Lin, Atrial fibrillation in primary aldosteronism. Horm. Metab. Res. 52, 357\u201365 (2020)","journal-title":"Horm. Metab. Res."},{"key":"3798_CR18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"P. Milliez, X. Girerd, P.-F. Plouin, J. Blacher, M.E. Safar, J.-J. Mourad, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45, 1243\u20138 (2005)","journal-title":"J. Am. Coll. Cardiol."},{"key":"3798_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2020.00121","volume":"11","author":"Z Meng","year":"2020","unstructured":"Z. Meng, Z. Dai, K. Huang, C. Xu, Y.-G. Zhang, H. Zheng, T.-Z. Liu, Long-term mortality for patients of primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 11, 121 (2020)","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"3798_CR20","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"P. Mulatero, S. Monticone, C. Bertello, A. Viola, D. Tizzani, A. Iannaccone, V. Crudo, J. Burrello, A. Milan, F. Rabbia, F. Veglio, Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 98, 4826\u201333 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","volume":"49","author":"F Buffolo","year":"2017","unstructured":"F. Buffolo, S. Monticone, J. Burrello, M. Tetti, F. Veglio, T. Williams, P. Mulatero, Is primary aldosteronism still largely unrecognized? Horm. Metab. Res. 49, 908\u201314 (2017)","journal-title":"Horm. Metab. Res."},{"key":"3798_CR22","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.3399\/bjgp18X694589","volume":"68","author":"SC K\u00e4yser","year":"2018","unstructured":"S.C. K\u00e4yser, J. Deinum, W.J. de Grauw, B.W. Schalk, H.J. Bor, J.W. Lenders, T.R. Schermer, M.C. Biermans, Prevalence of primary aldosteronism in primary care: a cross-sectional study. Br. J. Gen. Pract. 68, e114\u2013e122 (2018)","journal-title":"Br. J. Gen. Pract."},{"key":"3798_CR23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1055\/s-0043-119802","volume":"49","author":"J Funder","year":"2017","unstructured":"J. Funder, Primary aldosteronism: The next five years. Horm. Metab. Res. 49, 977\u201383 (2017)","journal-title":"Horm. Metab. Res."},{"key":"3798_CR24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/a-0958-0068","volume":"145","author":"L Handgriff","year":"2020","unstructured":"L. Handgriff, M. Reincke, [Primary aldosteronism - why is it still underdiagnosed in clinical practice?]. DMW - Dtsch. Medizinische Wochenschr. 145, 716\u201321 (2020)","journal-title":"DMW - Dtsch. Medizinische Wochenschr."},{"key":"3798_CR25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.31128\/AJGP-05-18-4587","volume":"47","author":"YY Lim","year":"2018","unstructured":"Y.Y. Lim, J. Shen, P.J. Fuller, J. Yang, Current pattern of primary aldosteronism diagnosis: Delayed and complicated. Aust. J. Gen. Pract. 47, 712\u20138 (2018)","journal-title":"Aust. J. Gen. Pract."},{"key":"3798_CR26","doi-asserted-by":"crossref","first-page":"e061671","DOI":"10.1136\/bmjopen-2022-061671","volume":"12","author":"AK Nainani","year":"2022","unstructured":"A.K. Nainani, J. Yang, S. Peters, G. Russell, I can\u2019t understand why others don\u2019t screen more\u2019: A qualitative study exploring why Australian general practitioners screen for primary aldosteronism. BMJ Open 12, e061671 (2022)","journal-title":"BMJ Open"},{"key":"3798_CR27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/endocrines3010003","volume":"3","author":"JG Ruiz-S\u00e1nchez","year":"2022","unstructured":"J.G. Ruiz-S\u00e1nchez, M. Pazos Guerra, D. Meneses, I. Runkle, Primary hyperaldosteronism: When to suspect it and how to confirm its diagnosis. Endocrines 3, 29\u201342 (2022)","journal-title":"Endocrines"},{"key":"3798_CR28","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata, M. Stowasser, W.F. Young, The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u2013916 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/08037051.2018.1527177","volume":"27","author":"B Williams","year":"2018","unstructured":"B. Williams, G. Mancia, W. Spiering, E. Agabiti Rosei, M. Azizi, M. Burnier, D. Clement, A. Coca, G. De Simone, A. Dominiczak, T. Kahan, F. Mahfoud, J. Redon, L. Ruilope, A. Zanchetti, M. Kerins, S. Kjeldsen, R. Kreutz, S. Laurent, G.Y.H. Lip, R. McManus, K. Narkiewicz, F. Ruschitzka, R. Schmieder, E. Shlyakhto, K. Tsioufis, V. Aboyans, I. Desormais, 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press 27, 314\u201340 (2018)","journal-title":"Blood Press"},{"key":"3798_CR30","doi-asserted-by":"publisher","unstructured":"X. Liu, S. Hao, J. Bian, Y. Lou, H. Zhang, H. Wu, J. Cai, W. Ma, Performance of aldosterone-to-renin ratio before washout of antihypertensive drugs in screening of primary aldosteronism. J Clin Endocrinol Metab. 21, dgae094 (2024). https:\/\/doi.org\/10.1210\/clinem\/dgae094","DOI":"10.1210\/clinem\/dgae094"},{"key":"3798_CR31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12020-023-03520-6","volume":"83","author":"X Li","year":"2024","unstructured":"X. Li, J. Liang, J. Hu, L. Ma, J. Yang, A. Zhang, Y. Jing, Y. Song, Y. Yang, Z. Feng, Z. Du, Y. Wang, T. Luo, W. He, X. Shu, S. Yang, Q. Li; Chongqing Primary Aldosteronism Study (CONPASS) Group, Screening for primary aldosteronism on and off interfering medications. Endocrine 83, 178\u201387 (2024)","journal-title":"Endocrine"},{"key":"3798_CR32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","volume":"51","author":"GL Schwartz","year":"2005","unstructured":"G.L. Schwartz, S.T. Turner, Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin. Chem. 51, 386\u201394 (2005)","journal-title":"Clin. Chem."},{"key":"3798_CR33","doi-asserted-by":"crossref","first-page":"684111","DOI":"10.3389\/fphar.2021.684111","volume":"12","author":"P J\u0119drusik","year":"2021","unstructured":"P. J\u0119drusik, B. Symonides, J. Lewandowski, Z. Gaciong, The effect of antihypertensive medications on testing for primary aldosteronism. Front. Pharmacol. 12, 684111 (2021)","journal-title":"Front. Pharmacol."},{"key":"3798_CR34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","volume":"76","author":"VM Montori","year":"2001","unstructured":"V.M. Montori, G.L. Schwartz, A.B. Chapman, E. Boerwinkle, S.T. Turner, Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin. Proc. 76, 877\u201382 (2001)","journal-title":"Mayo Clin. Proc."},{"key":"3798_CR35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, F. Veglio, Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertens. (Dallas, Tex. 1979) 40, 897\u2013902 (2002)","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"key":"3798_CR36","first-page":"578","volume":"131","author":"A \u0141ebek-Szata\u0144ska","year":"2021","unstructured":"A. \u0141ebek-Szata\u0144ska, L. Papierska, P. Glinicki, W. Zgliczy\u0144ski, Withdrawal of all medications is not necessary for accurate screening for primary aldosteronism: preliminary results. Pol. Arch. Intern. Med. 131, 578\u201381 (2021)","journal-title":"Pol. Arch. Intern. Med."},{"key":"3798_CR37","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/clinem\/dgac460","volume":"107","author":"P Mulatero","year":"2022","unstructured":"P. Mulatero, C. Bertello, F. Veglio, S. Monticone, Approach to the patient on antihypertensive therapy: screen for primary aldosteronism. J. Clin. Endocrinol. Metab. 107, 3175\u201381 (2022)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR38","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","volume":"105","author":"A Vaidya","year":"2020","unstructured":"A. Vaidya, R.M. Carey, Evolution of the primary aldosteronism syndrome: Updating the approach. J. Clin. Endocrinol. Metab. 105, 3771\u201383 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-11-0914","volume":"166","author":"M Solar","year":"2012","unstructured":"M. Solar, E. Malirova, M. Ballon, R. Pelouch, J. Ceral, Confirmatory testing in primary aldosteronism: Extensive medication switching is not needed in all patients. Eur. J. Endocrinol. 166, 679\u201386 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"3798_CR40","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1210\/clinem\/dgaa080","volume":"105","author":"GP Rossi","year":"2020","unstructured":"G.P. Rossi, G. Ceolotto, G. Rossitto, G. Maiolino, M. Cesari, T.M. Seccia, Effects of mineralocorticoid and AT1 receptor antagonism on the aldosterone-renin ratio in primary aldosteronism\u2014the EMIRA wtudy. J. Clin. Endocrinol. Metab. 105, 2060\u20137 (2020)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3798_CR41","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4158\/EP-2020-0277","volume":"26","author":"Y Tezuka","year":"2020","unstructured":"Y. Tezuka, A.F. Turcu, Mineralocorticoid receptor antagonists decrease the rates of positive screening for primary aldosteronism. Endocr. Pract. 26, 1416\u201324 (2020)","journal-title":"Endocr. Pract."},{"key":"3798_CR42","unstructured":"M. Araujo-Castro, J.G. Ruiz-S\u00e1nchez, P. Parra Ram\u00edrez, P. Mart\u00edn Rojas-Marcos, A. Aguilera-Saborido, J.F. G\u00f3mez Cerezo, N. L\u00f3pez Lazareno, M.E. Torregrosa Quesada, J. Gorrin Ramos, J. Oriola, E. Poch, A. Oliveras, J.V. M\u00e9ndez Monter, I. G\u00f3mez Muriel, M.R. Bella-Cueto, E. Mercader Cidoncha, I. Runkle, F.A. Hanzu, and S. A. of S. (AEC) In representation of the following medical Spanish societies: Spanish Society of Endocrinology and Nutrition (SEEN), Spanish Society of Cardiology (SEC), Spanish Society of Nephrology (SEN), Spanish Society of Internal Medicine (SEMI), Spanish Radiology S, Endocrine (2024)."},{"key":"3798_CR43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","volume":"35","author":"A Vaidya","year":"2022","unstructured":"A. Vaidya, G.L. Hundemer, K. Nanba, W.W. Parksook, J.M. Brown, Primary aldosteronism: State-of-the-art review. Am. J. Hypertens. 35, 967\u201388 (2022)","journal-title":"Am. J. Hypertens."},{"key":"3798_CR44","doi-asserted-by":"crossref","first-page":"101399","DOI":"10.1016\/j.beem.2020.101399","volume":"34","author":"F Buffolo","year":"2020","unstructured":"F. Buffolo, S. Monticone, A. Pecori, J. Pieroni, I. Losano, G. Cavagli\u00e0, M. Tetti, F. Veglio, P. Mulatero, The spectrum of low-renin hypertension. Best. Pract. Res. Clin. Endocrinol. Metab. 34, 101399 (2020)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03798-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:00:53Z","timestamp":1722427253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03798-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3798"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03798-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}